Special Issue Title: Update on Cervical Cancer Prevention and Screening

· Print Special Issue Flyer

· Deadline for manuscript submissions: 30 March 2021

Guest Editor

Prof. Dr. Tiziano Maggino

Department Obstetrics and Gynecology, “Dell'Angelo Hospital -Zelarino 30174, Mestre-Venezia, Italy

Interests: Obstetrics and gynecology; Cervical cancer screening; Gynecology Oncology

Dr. Vasilios Pergialiotis

1.First Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece; 2. Laboratory of Experimental Surgery and Surgical Research N.S Christeas, National and Kapodistrian University of Athens, Athens, Greece

E-Mail

Interests: Cervical Cancer

Special Issue Information

Dear Colleagues,

Cervical cancer of the uterus is a neoplasia in which the scientific progress has produced an impressive reduction in the incidence and mortality.

This is particurlaly linked with several development in the knowledge of the natural history of the disease:

● The patogenetic role of HPV infection has been definivelly well established with a clear multistep process of development;
● The organized population based cervical cancer screening programmes at national and regional level have produced an increasing detection of dysplasic and early invasive lesions particularly in young women;
● Introduction of HPV- high risk test as primary screening test has produce an anticipation of the detection of the dysplasic lesions;
● More conservative treatments have been proposed for the screen-detected lesions with consequent respect of the anatomo-functional integrity of the uterine cervix;
● Recently some markers of progression may be identified aiming to select which lesion requires follow-up istead of immediate treatment;
● Vaccination agaist HPV has been introduced in many western countries with an expected further reduction in the incidence of the disease;
● The first cohorts of vaccinated girls have reached the age of screening programme and the consequance of this implies a substantial changes in the strategies of the screening programme in term of organization, test to adopt, frequancy and interpretation of the results.

The special issue of the journal will offer to the readers the highlights of the researches in the field presented by authors with recognized international experience and reporting, in some part, the actual position of the national group of cervical screening programmes in Italy.

Prof. Dr. Tiziano Maggino

Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. We normally offer a discount greater than 30% (APC: $850) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Planned Paper

Type: Review
Title: Trend of cone dimension and CIN extension: 30 years experience of a tertiary center
Author: Mario Preti

Title: Up date on HPV-vaccines and cervical cancer incidence
Author: V. Baldo (Padua) 

Title: Trend of cone dimension and CIN extension: 30 years experience of a tertiary center
Author: M. Zappa (Florence)

Title: The follow-up of women treated for CIN 2 or 3: synopsis of the recommendations from the italian cervical cancer rprevention multisocietal group
Author: P. Giorgi Rossi (Reggio Emilia), P. Garutti (Ferrara) and Multisocietal Group

Title: Recommendation on HPV vaccination in women treated for CIN 2 or 3: systematic review and recommendation from the italian cervical cancer prevention multisocietal group
Author: P. Giorgi Rossi (Reggio Emilia), P. Garutti (Ferrara) and Italian Multisocietal Group

Title: The methodological framework  adopted by the italian cervical cancer prevention multisocietal group in the production of recommendation
Author: P. Giorgi Rossi (Reggio Emilia) and Italian Multisocietal Group

Title: Follow-up instead of immediate treatment in patients with CIN 2 lesion: study of veneto region
Author: M.Zorzi (Padua), A. Del Mistro (Padua) and al